Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HPV vaccination: the promise & problems.

R Sankaranarayanan1

  • 1Screening Group, International Agency for Research on Cancer, Lyon, France. sankar@iarc.fr

The Indian Journal of Medical Research
|November 11, 2009
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

926
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
926
Vaccinations01:51

Vaccinations

51.1K
Overview
51.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating microstructural and machine learning predictive models for friction drilling of sustainable snail shell reinforced aluminium matrix composites.

Scientific reports·2025
Same author

Assessment of Registry-Based Surveillance Statistics Used for Cancer Control in the Dindigul District in South India.

Journal of registry management·2023
Same author

Prevalence and predictors of bacterial vaginosis in HIV-infected women in Maharashtra, India.

International journal of STD & AIDS·2020
Same author

In vitro bioactivity, mechanical behavior and antibacterial properties of mesoporous SiO<sub>2</sub>-CaO-Na<sub>2</sub>O-P<sub>2</sub>O<sub>5</sub> nano bioactive glass ceramics.

Journal of the mechanical behavior of biomedical materials·2019
Same author

Deformation of dark solitons in a <math></math> -invariant variable coefficients nonlocal nonlinear Schrödinger equation.

Chaos (Woodbury, N.Y.)·2018
Same author

Overview of Cervical Cancer in the Developing World.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2018
Same journal

In conversation with Dr Harlan M. Krumholz: On preprints, the story behind medRxiv.

The Indian journal of medical research·2026
Same journal

Clay pots for reducing fluoride concentration in drinking water.

The Indian journal of medical research·2026
Same journal

Telephonic reminders for improving anti-rabies vaccination completion at a rural primary health centre: A quality improvement initiative.

The Indian journal of medical research·2026
Same journal

BMI-dependent methylation and clinical signatures in North Indian women with PCOS.

The Indian journal of medical research·2026
Same journal

Focused ultrasound-induced blood-brain barrier modulation for drug delivery in recurrent glioblastoma: A systematic review.

The Indian journal of medical research·2026
Same journal

Prevalence of metabolic dysfunction associated steatotic liver disease in type 2 diabetes mellitus in India: A systematic review and meta-analysis.

The Indian journal of medical research·2026
See all related articles

Human papillomavirus (HPV) vaccines are crucial for preventing cervical cancer, but high costs and delivery challenges hinder their use in developing nations. Reducing costs and improving delivery are key to wider HPV vaccination.

Area of Science:

  • Oncology
  • Vaccinology
  • Public Health

Background:

  • Cervical cancer disproportionately affects developing countries, with HPV genotypes 16 and 18 causing 70% of cases.
  • Current HPV vaccines offer high protection against HPV 16/18 and related precancerous lesions.

Purpose of the Study:

  • To identify challenges and propose solutions for widespread implementation of HPV vaccination programs in developing countries.
  • To address barriers including vaccine cost, delivery platforms, long-term protection, and public acceptance.

Main Methods:

  • Literature review and analysis of existing challenges in HPV vaccine deployment.
  • Discussion of factors influencing vaccine uptake and program effectiveness.

Main Results:

Related Experiment Videos

  • Key challenges include high vaccine costs, inadequate delivery systems for adolescents, and socio-political barriers.
  • Unresolved issues include long-term efficacy, cross-protection, and the need for booster doses.

Conclusions:

  • Reducing HPV vaccine costs and simplifying vaccination schedules are essential.
  • Strengthening adolescent vaccine delivery platforms is critical for successful HPV vaccine introduction in developing countries.